1---2name: analyze-iss-antitrust-transaction-structure3task_id: antitrust-competition/analyze-iss-antitrust-transaction-structure4description: Closes gaps in deal-structure antitrust risk analysis including hell-or-high-water provision adequacy, reverse termination fee sufficiency, outside date feasibility, and hot-document identification.5activates_for: [planner, solver, checker]6metadata:7 source: https://skillmd.com/skills/finchipaiorg/analyze-iss-antitrust-transaction-structure8---910# Skill: Antitrust Transaction Structure Analysis1112## 1. Subject-matter triage13- Treat the assignment as an antitrust deal-review memo, not a generic diligence summary.14- Identify whether the source set includes merger agreement drafts, board decks, banker materials, emails, schedules, and regulatory strategy materials.15- Separate transactional structure issues from substantive competition issues, then connect them back to clearance risk and closing mechanics.16- If multiple jurisdictions, business lines, or product overlaps are present, analyze each as a distinct clearance track rather than collapsing them into one global assessment.1718## 2. Failure modes the skill is correcting19- The analysis stops at “antitrust risk exists” without tying that risk to a specific remedy posture, filing path, or closing consequence.20- The analysis ignores the practical force of a reverse termination fee and whether it is large enough to change behavior rather than merely allocate downside.21- The analysis treats a divestiture cap, remedy carve-out, or consent limitation as boilerplate instead of testing whether it weakens the buyer’s clearance commitment.22- The analysis misses whether the outside date leaves enough runway for clearance review, second requests, remedy negotiation, or post-clearance waiting periods.23- The analysis overlooks internal materials that frame the deal as a pricing, capacity, market-power, or competitor-removal story and therefore require careful document handling.24- The analysis mentions overlap but does not connect overlap to likely unilateral, coordinated, or vertical theories of harm.25- The analysis identifies concerns but does not end with concrete recommendations on filings, term changes, preservation, and remedy strategy.2627## 3. Legal frameworks / domain conventions that apply28- Use the relevant merger-control standard for each jurisdiction implicated by the deal; anchor the analysis in the governing competition statute and agency practice for that forum.29- For U.S. review, frame the substantive analysis under Section 7 of the Clayton Act and the Hart-Scott-Rodino Act filing regime where applicable; for other jurisdictions, use the local merger-control statute and clearance test.30- Assess concentration, overlap, and competitive effects using the standard merger-screen framework: relevant market, shares, concentration, entry, diversion, and likely remedy path.31- Treat a hell-or-high-water commitment as meaningful only if it obligates the buyer to pursue and accept commercially reasonable remedies needed for clearance; remedy caps, asset exclusions, or “no structural divestiture” language may materially dilute it.32- Evaluate a reverse termination fee as an incentive device: it should be measured against the transaction’s risk profile and closing economics, not treated as sufficient merely because it exists.33- Test the outside date against expected agency timing, second-request exposure, litigation risk, and any post-clearance waiting period or local sequencing requirement.34- Treat internal documents discussing pricing power, reduced competition, market control, customer capture, or competitor removal as hot documents relevant to intent and effects.35- Treat non-compete and similar retention restrictions as part of the competition analysis where departing personnel or management could compete post-closing.36- Use merger-specific remedy concepts: divestiture buyer viability, fix-it-first feasibility, conduct remedy limits, and whether the proposed buyer restores competitive conditions.3738## 4. Analytical scaffolds391. Map the transaction40 - Identify the parties, business lines, products, geography, and review jurisdictions.41 - Enumerate each overlap, adjacency, and customer-facing interaction before analyzing effects.422. Assess substantive antitrust risk43 - Define the likely relevant market(s) at the level supported by the documents.44 - Analyze concentration, diversion, customer switching, capacity, and entry.45 - State the likely theory of harm for each overlap: unilateral effects, coordinated effects, foreclosure, or information-based concerns.463. Test the documentary record for hot issues47 - Review board decks, banker books, management presentations, emails, and draft strategy materials for competition-sensitive language.48 - Flag each item by document type and why it is sensitive.49 - Recommend preservation, legal hold, and privilege review steps where the record suggests antitrust intent risk.504. Analyze deal-protection mechanics51 - Evaluate whether the hell-or-high-water covenant is broad enough to require meaningful remedy pursuit.52 - Check whether any remedy cap, carve-out, or buyer consent right undermines the covenant.53 - Assess whether the reverse termination fee is large enough to create real clearance incentives.54 - Test whether the outside date accommodates the likely clearance path.555. Evaluate remedies and filing strategy56 - Identify whether divestiture, conduct commitments, or behavioral undertakings are likely to be requested.57 - Assess potential remedy buyers for capability, independence, and operational fit.58 - Determine whether filings should be made early, simultaneously, sequentially, or with a hold-separate strategy.596. Close each issue with consequences60 - For every issue, tie the concern to a source-document metric or transactional fact, cross-reference the clause or exhibit that affects it, and state the closing, regulatory, or litigation consequence.617. Assign severity consistently62 - Use a defined ordinal severity scale throughout the memo and apply it uniformly to each issue.6364## 5. Vertical / structural / temporal relationships65- Identify how the merger agreement, disclosure schedules, internal strategy materials, and regulatory communications interact.66- If one provision limits another, explain the hierarchy in practical terms: e.g., a remedy covenant may be narrowed by a cap, timing gate, or consent standard.67- Track sequencing risk: signing, filing, waiting period, second request, remedy discussions, and closing should be analyzed in temporal order.68- If the record contains multiple products, regions, or clearance authorities, analyze them separately first and then state the combined closing timetable.69- Distinguish pre-signing risk flags from post-signing obligations so the memo does not conflate diligence concerns with covenants.7071## 6. Output structure conventions72- Begin with a short executive summary stating the overall antitrust risk level and the likely clearance posture.73- Use a clear severity scale near the front of the memo and apply it to each issue consistently.74- Organize the body in a conventional issues-memo shape:75 - Transaction overview and review scope76 - Competitive overlap and market context77 - Hot documents and document-handling risks78 - Deal-protection and closing-condition analysis79 - Remedies and filing strategy80 - Recommended actions81- For each issue, include:82 - Severity83 - Legal basis with the controlling authority named84 - The relevant factual trigger from the documents85 - The interaction with another clause, schedule, or document86 - The downstream consequence for clearance, timing, or economics87- Do not state antitrust conclusions in conclusory form without naming the governing statute, regulation, or doctrinal standard supporting them.88- End with a Recommended Actions block that assigns each action to a responsible role and ties it to a transaction or regulatory milestone.89- Include document-preservation and privilege-review steps whenever internal materials suggest competition-sensitive intent.90- If the source set supports more than one filing path or remedy posture, list each path separately and compare the tradeoffs rather than selecting a single default.